Bleeding Disorders Treatment Market - Segmented By Drug Class (Fibrin Sealant, Desmopressin, Antibrinolytics, Recombinant Coagulation Factor Concentrates And Plasma-Derived Coagulation Factor Concentrates), By Type (vWD, Hemophilia A, Hemophilia B), & By Region - Global Forecast – 2023

Bleeding Disorders Treatment Market - Segmented By Drug Class (Fibrin Sealant, Desmopressin, Antibrinolytics, Recombinant Coagulation Factor Concentrates And Plasma-Derived Coagulation Factor Concentrates), By Type (vWD, Hemophilia A, Hemophilia B), & By Region - Global Forecast – 2023

ID: 3361 | Pages: 181 | April 2018 | Region: Global


The Global Bleeding Disorders Treatment Market was worth USD 12.03 billion in 2018 and is estimated to be growing at a CAGR of 7.90%, to reach USD 17.59 billion by 2023. The market is showcasing evident potential in the mentioned forecasting period. A bleeding disorder is a condition in which blood clotting (also called coagulation) doesn’t take place properly in case of any wound or any cut which might lead to some serious problem because of too much loss of blood from the body.

There are many type of Bleeding Disorders, but the most common ones seen are Hemophilia A, Hemophilia B and von Willebrand Disease  (vWD). A bleeding Disorder is generally diagnosed by any of these three methods: Complete Blood Count (CBC), Platelet Aggregation Test and bleeding time. There are various treatment methods depending on the type of bleeding disorder and its severity. Treatments include Iron Supplementation pills, Blood transfusion and other methods.

With careless lifestyle of teenagers and not taking care of their diet, iron deficiency in their body can take place easily, which is the root cause for bleeding disorders.  Blood disorder cases are increasing worldwide at a very fast rate also because of the adulteration of food. Also, the fact that most of the bleeding disorders are inherited and cannot be completely cured is also driving this market. On the other hand, factors such as, high cost of treatment including medication and lack of skilled practitioners to cure these type of disorders are challenging this market.

The Global market for Bleeding Disorders Treatment is broadly categorized by Drug Class and by Disorder Type. On the basis of Drug Class, it is further sub-categorized into Fibrin Sealant, Desmopressin, Antibrinolytics, Recombinant Coagulation Factor Concentrates and Plasma Derived Coagulation Factor Concentrates. On the basis of disorder type, it is sub-categorized into Hemophilia A, Hemophilia B ad vWD. The recombinant coagulation factor concentrates segment is expected to grow the fastest in the mentioned forecast period. This is because of the increased R&D in this market and increasing focus of pharmaceutical companies on recombinant products.

Geographically, global market is further sub-categorized into North America, Latin America, Middle East & Africa, Asia-Pacific and Europe. For the upcoming years, Asia-Pacific is expected to grow the fastest in this market followed by Latin America. This can be attributed to the fact that local governments are becoming more concerned about the healthcare in these regions and increasing per capita income in these regions. North America has the biggest market share among all the regions.

Some of the major companies dominating the market, by their products and services include CSL Behring, Pfizer Inc., Novo Nordisk, Bayer AG, Biogen Inc., Shire Plc., Medline Plus, Janssen Global Services, LLC and Grifos SA.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Drug Class                   

                                5.1.1 Introduction           

                                5.1.2 Fibrin Sealant         

                                5.1.3 Desmopressin       

                                5.1.4 Antibrinolytics       

                                5.1.5 Recombinant Coagulation Factor Concentrates      

                                5.1.6 Plasma Derived Coagulation Factor Concentrates  

                                5.1.7  Y-o-Y Growth Analysis, By Drug Class          

                                5.1.8  Market Attractiveness Analysis, By Drug Class        

                                5.1.9  Market Share Analysis, By Drug Class         

                5.2 Type                              

                                5.2.1 Introduction           

                                5.2.2 vWD           

                                5.2.3 Hemophilia A         

                                5.2.4 Hemophilia B          

                                5.2.5 Y-o-Y Growth Analysis, By Type     

                                5.2.6 Market Attractiveness Analysis, By Type   

                                5.2.7 Market Share Analysis, By Type     

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Drug Class

                                                6.1.3.3 By Type

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Drug Class

                                                6.1.4.3 By Type

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Drug Class

                                                6.1.5.3 By Type

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 CSL Behring                

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Pfizer Inc.                    

                8.3 Novo Nordisk                            

                8.4 Bayer AG                     

                8.5 Biogen Inc.                  

                8.6 Shire Plc.                      

                8.7 LLC                 

                8.8 Medline Plus                              

                8.9 Janssen Global Services                        

                8.10 Grifos SA                   

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Global Bleeding Disorders Treatment Market By Region, From 2018-2023 ( USD Billion )
  2. Global Bleeding Disorders Treatment Market By Drug Class, From 2018-2023 ( USD Billion )
  3. Global Fibrin Sealant Market By Region, From 2018-2023 ( USD Billion )
  4. Global Desmopressin Market By Region, From 2018-2023 ( USD Billion )
  5. Global Antibrinolytics Market By Region, From 2018-2023 ( USD Billion )
  6. Global Recombinant Coagulation Factor Concentrates Market By Region, From 2018-2023 ( USD Billion )
  7. Global Plasma Derived Coagulation Factor Concentrates Market By Region, From 2018-2023 ( USD Billion )
  8. Global Bleeding Disorders Treatment Market By Type, From 2018-2023 ( USD Billion )
  9. Global vWD Market By Region, From 2018-2023 ( USD Billion )
  10. Global Hemophilia A Market By Region, From 2018-2023 ( USD Billion )
  11. Global Hemophilia B Market By Region, From 2018-2023 ( USD Billion )
  12. North America Bleeding Disorders Treatment Market By Drug Class, From 2018-2023 ( USD Billion )
  13. North America Fibrin Sealant Market By Region, From 2018-2023 ( USD Billion )
  14. North America Desmopressin Market By Region, From 2018-2023 ( USD Billion )
  15. North America Antibrinolytics Market By Region, From 2018-2023 ( USD Billion )
  16. North America Recombinant Coagulation Factor Concentrates Market By Region, From 2018-2023 ( USD Billion )
  17. North America Plasma Derived Coagulation Factor Concentrates Market By Region, From 2018-2023 ( USD Billion )
  18. North America Bleeding Disorders Treatment Market By Type, From 2018-2023 ( USD Billion )
  19. North America vWD Market By Region, From 2018-2023 ( USD Billion )
  20. North America Hemophilia A Market By Region, From 2018-2023 ( USD Billion )
  21. North America Hemophilia B Market By Region, From 2018-2023 ( USD Billion )
  22. United States Bleeding Disorders Treatment Market By Drug Class, From 2018-2023 ( USD Billion )
  23. United States Bleeding Disorders Treatment Market By Type, From 2018-2023 ( USD Billion )
  24. Canada Bleeding Disorders Treatment Market By Drug Class, From 2018-2023 ( USD Billion )
  25. Canada Bleeding Disorders Treatment Market By Type, From 2018-2023 ( USD Billion )
  26. Europe Bleeding Disorders Treatment Market By Drug Class, From 2018-2023 ( USD Billion )
  27. Europe Fibrin Sealant Market By Region, From 2018-2023 ( USD Billion )
  28. Europe Desmopressin Market By Region, From 2018-2023 ( USD Billion )
  29. Europe Antibrinolytics Market By Region, From 2018-2023 ( USD Billion )
  30. Europe Recombinant Coagulation Factor Concentrates Market By Region, From 2018-2023 ( USD Billion )
  31. Europe Plasma Derived Coagulation Factor Concentrates Market By Region, From 2018-2023 ( USD Billion )
  32. Europe Bleeding Disorders Treatment Market By Type, From 2018-2023 ( USD Billion )
  33. Europe vWD Market By Region, From 2018-2023 ( USD Billion )
  34. Europe Hemophilia A Market By Region, From 2018-2023 ( USD Billion )
  35. Europe Hemophilia B Market By Region, From 2018-2023 ( USD Billion )
  36. U.K. Bleeding Disorders Treatment Market By Drug Class, From 2018-2023 ( USD Billion )
  37. U.K. Bleeding Disorders Treatment Market By Type, From 2018-2023 ( USD Billion )
  38. Germany Bleeding Disorders Treatment Market By Drug Class, From 2018-2023 ( USD Billion )
  39. Germany Bleeding Disorders Treatment Market By Type, From 2018-2023 ( USD Billion )
  40. France Bleeding Disorders Treatment Market By Drug Class, From 2018-2023 ( USD Billion )
  41. France Bleeding Disorders Treatment Market By Type, From 2018-2023 ( USD Billion )
  42. Italy Bleeding Disorders Treatment Market By Drug Class, From 2018-2023 ( USD Billion )
  43. Italy Bleeding Disorders Treatment Market By Type, From 2018-2023 ( USD Billion )
  44. Spain Bleeding Disorders Treatment Market By Drug Class, From 2018-2023 ( USD Billion )
  45. Spain Bleeding Disorders Treatment Market By Type, From 2018-2023 ( USD Billion )
  46. Asia-Pacific Bleeding Disorders Treatment Market By Drug Class, From 2018-2023 ( USD Billion )
  47. Asia-Pacific Fibrin Sealant Market By Region, From 2018-2023 ( USD Billion )
  48. Asia-Pacific Desmopressin Market By Region, From 2018-2023 ( USD Billion )
  49. Asia-Pacific Antibrinolytics Market By Region, From 2018-2023 ( USD Billion )
  50. Asia-Pacific Recombinant Coagulation Factor Concentrates Market By Region, From 2018-2023 ( USD Billion )
  51. Asia-Pacific Plasma Derived Coagulation Factor Concentrates Market By Region, From 2018-2023 ( USD Billion )
  52. Asia-Pacific Bleeding Disorders Treatment Market By Type, From 2018-2023 ( USD Billion )
  53. Asia-Pacific vWD Market By Region, From 2018-2023 ( USD Billion )
  54. Asia-Pacific Hemophilia A Market By Region, From 2018-2023 ( USD Billion )
  55. Asia-Pacific Hemophilia B Market By Region, From 2018-2023 ( USD Billion )
  56. Japan Bleeding Disorders Treatment Market By Drug Class, From 2018-2023 ( USD Billion )
  57. Japan Bleeding Disorders Treatment Market By Type, From 2018-2023 ( USD Billion )
  58. China Bleeding Disorders Treatment Market By Drug Class, From 2018-2023 ( USD Billion )
  59. China Bleeding Disorders Treatment Market By Type, From 2018-2023 ( USD Billion )
  60. India Bleeding Disorders Treatment Market By Drug Class, From 2018-2023 ( USD Billion )
  61. India Bleeding Disorders Treatment Market By Type, From 2018-2023 ( USD Billion )
  62. Australia Bleeding Disorders Treatment Market By Drug Class, From 2018-2023 ( USD Billion )
  63. Australia Bleeding Disorders Treatment Market By Type, From 2018-2023 ( USD Billion )
  64. South Korea Bleeding Disorders Treatment Market By Drug Class, From 2018-2023 ( USD Billion )
  65. South Korea Bleeding Disorders Treatment Market By Type, From 2018-2023 ( USD Billion )
  66. Latin America Bleeding Disorders Treatment Market By Drug Class, From 2018-2023 ( USD Billion )
  67. Latin America Fibrin Sealant Market By Region, From 2018-2023 ( USD Billion )
  68. Latin America Desmopressin Market By Region, From 2018-2023 ( USD Billion )
  69. Latin America Antibrinolytics Market By Region, From 2018-2023 ( USD Billion )
  70. Latin America Recombinant Coagulation Factor Concentrates Market By Region, From 2018-2023 ( USD Billion )
  71. Latin America Plasma Derived Coagulation Factor Concentrates Market By Region, From 2018-2023 ( USD Billion )
  72. Latin America Bleeding Disorders Treatment Market By Type, From 2018-2023 ( USD Billion )
  73. Latin America vWD Market By Region, From 2018-2023 ( USD Billion )
  74. Latin America Hemophilia A Market By Region, From 2018-2023 ( USD Billion )
  75. Latin America Hemophilia B Market By Region, From 2018-2023 ( USD Billion )
  76. Brazil Bleeding Disorders Treatment Market By Drug Class, From 2018-2023 ( USD Billion )
  77. Brazil Bleeding Disorders Treatment Market By Type, From 2018-2023 ( USD Billion )
  78. Argentina Bleeding Disorders Treatment Market By Drug Class, From 2018-2023 ( USD Billion )
  79. Argentina Bleeding Disorders Treatment Market By Type, From 2018-2023 ( USD Billion )
  80. Mexico Bleeding Disorders Treatment Market By Drug Class, From 2018-2023 ( USD Billion )
  81. Mexico Bleeding Disorders Treatment Market By Type, From 2018-2023 ( USD Billion )
  82. Rest of Latin America Bleeding Disorders Treatment Market By Drug Class, From 2018-2023 ( USD Billion )
  83. Rest of Latin America Bleeding Disorders Treatment Market By Type, From 2018-2023 ( USD Billion )
  84. Middle East & Africa Bleeding Disorders Treatment Market By Drug Class, From 2018-2023 ( USD Billion )
  85. Middle East & Africa Fibrin Sealant Market By Region, From 2018-2023 ( USD Billion )
  86. Middle East & Africa Desmopressin Market By Region, From 2018-2023 ( USD Billion )
  87. Middle East & Africa Antibrinolytics Market By Region, From 2018-2023 ( USD Billion )
  88. Middle East & Africa Recombinant Coagulation Factor Concentrates Market By Region, From 2018-2023 ( USD Billion )
  89. Middle East & Africa Plasma Derived Coagulation Factor Concentrates Market By Region, From 2018-2023 ( USD Billion )
  90. Middle East & Africa Bleeding Disorders Treatment Market By Type, From 2018-2023 ( USD Billion )
  91. Middle East & Africa vWD Market By Region, From 2018-2023 ( USD Billion )
  92. Middle East & Africa Hemophilia A Market By Region, From 2018-2023 ( USD Billion )
  93. Middle East & Africa Hemophilia B Market By Region, From 2018-2023 ( USD Billion )
  94. Middle East Bleeding Disorders Treatment Market By Drug Class, From 2018-2023 ( USD Billion )
  95. Middle East Bleeding Disorders Treatment Market By Type, From 2018-2023 ( USD Billion )
  96. Africa Bleeding Disorders Treatment Market By Drug Class, From 2018-2023 ( USD Billion )
  97. Africa Bleeding Disorders Treatment Market By Type, From 2018-2023 ( USD Billion )
Middle East And Africa Angina Pectoris Drugs Market By Therapeutic Class ( Beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth...
Asia Pacific Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, A...
Europe Angina Pectoris Drugs Market By Therapeutic Class ( Beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Fo...
North America Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, ...
Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts ...
Middle East And Africa Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) A...
Latin America Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Reg...
Asia Pacific Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Regi...
Europe Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Region - I...
North America Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Reg...
Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Region - Industry...
Pharmaceutical Gelatin Market By Function (stabilizers, Thickeners, Gelling Agents And Others) , By Source( Pig Skin, Bovine Hides, Bones And Others), By Application ( Hard Capsules, Soft Capsules, Microencapsulatio...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.